
On Nov 30, 2018, Dr. Xiaoyan Chu, Senior Principal Scientist at Merck shared her latest research findings on how endogenous biomarkers are being investigated as probes for drug-transporter interactions. Her presentation provided an overview of recently identified biomarkers for studying the inhibition of liver and kidney transporters including the current strategies, utility, limitations and future […]